IP Library Granted Patent US 7,314,746
Granted Patent B2
US 7,314,746 · App. 10/527,618 · Granted Jan 1, 2008

Apparatus and method for preparative scale purification of nucleic acids

Assignee: Valentis, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,314,746
App. No.
10/527,618
Granted
Jan 1, 2008
Kind
B2
Abstract

Apparatus and methods are described for pharmaceutical grade manufacture extrachromosomal nucleic acids from cell lysates using flotation to separate and eliminate undesired insoluble cellular debris including chromosomal DNA from the lysates. A gas is introduced to controllably generate bubbles that reduce the density of the cell debris and create a buoyant flocculent phase that can be readily separated from, and thus provide, a substantially clarified fluid lysate phase that is enriched in extrachromosomal DNA but substantially depleted of cellular proteins and chromosomal DNA.

Claims (21)

1. A method of producing a clarified cell lysate comprising plasmid DNA from an alkaline bacterial cell lysate, comprising the steps of:

introducing a suspension of bacterial cells into a fluid flow comprising an alkaline lysis buffer and an entrainment of gas, wherein the cells are flowably mixed with the cell lysis buffer together with the gas thereby forming a cell lysis mixture;

introducing a precipitation buffer into the fluid flow comprising the cell lysis mixture, thereby forming a precipitated lysate;

introducing a pH adjustment buffer into the precipitated lysate and combining the pH adjustment buffer and the precipitated lysate prior to separating the mixture;

separating the mixture into a buoyant flocculent phase comprising precipitated cell debris and a fluid phase comprising a substantially clarified cell lysate; and

isolating the clarified cell lysate.

2. A method of producing a clarified cell lysate comprising plasmid DNA from an alkaline bacterial cell lysate, comprising the steps of:

introducing a suspension of bacterial cells into a fluid flow comprising an alkaline lysis buffer and an entrainment of gas, wherein the cells are flowably mixed with the cell lysis buffer together with the gas thereby forming a cell lysis mixture;

introducing a precipitation buffer into the fluid flow comprising the cell lysis mixture, thereby forming a cell debris precipitate in the cell lysis mixture;

introducing the cell lysis mixture including the cell debris precipitate into a lysate separation tank and separating the mixture into a buoyant flocculent phase comprising the precipitated cell debris and a fluid phase comprising a clarified cell lysate, and isolating the substantially clarified cell lysate.

3. A method of producing a clarified cell lysate comprising plasmid DNA from an alkaline bacterial cell lysate, comprising the steps of:

introducing a suspension of bacterial cells into a fluid flow comprising an alkaline lysis buffer and an entrainment of gas and flowably mixing the cells with the cell lysis buffer together with the gas by passage through a first static mixer, thereby forming a cell lysis mixture;

introducing a precipitation buffer into the fluid flow comprising the cell lysis mixture and flowably mixing the cell lysis mixture with the precipitation buffer by passage through a second static mixer, thereby forming a cell debris precipitate in the cell lysis mixture;

introducing a pH adjustment buffer into the fluid flow comprising the cell debris precipitate and flowably mixing the cell lysis mixture with the pH adjustment buffer by passage through a third static mixer, thereby forming a pH adjusted cell lysis mixture;

flowing the pH adjusted cell lysis mixture into a lysate separation tank for separating the cell lysis mixture into a buoyant flocculent phase comprising the precipitated cell debris and a fluid phase comprising a substantially clarified cell lysate;

obtaining the substantially clarified cell lysate from under the buoyant flocculent phase; and

filtering the substantially clarified cell lysate to form a clarified cell lysate.

4. The method of claim 3 , wherein the gas is introduced via a gas port through which a gas is forced under pressure into the fluid flow thereby controllably forming bubbles in the cell lysis mixture.

5. The method of claim 4 , wherein the gas port comprises an aperture comprising a plurality of pores.

6. The method of claim 5 , wherein the pores have an average diameter of less than 5 microns.

7. The method of claim 5 , wherein the aperture comprising a plurality of pores is a sparge stone or disk filter comprising pores having an average diameter of 2 microns or less.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 6, 2015
From: TRIPLEPOINT CAPITAL LLC
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 036739/0195 →
SECURITY AGREEMENT Recorded Oct 4, 2011
From: JUVARIS BIOTHERAPEUTICS, INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 027015/0765 →
MERGER Recorded Oct 6, 2010
From: VALENTIS, INC.
To: URIGEN PHARMACEUTICALS, INC.
Reel/Frame 025095/0274 →
Continuity (2)
Provisional Application 6041061700 · Sep 13, 2002
Related Publication 20060166331A1 · Jul 27, 2006